Joseph H Wender Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 4 days ago
Joseph H Wender has an estimated net worth of at least $11.1 million*, as of Oct. 29, 2025. They own 64,035 shares of IONS stock. They have sold 100,800 shares of IONS stock since 2021, for an estimated $4.3 million.
Joseph H Wender $IONS SEC Form 4 Insider Trading
Joseph H Wender has filed a total of 11 insider trades in $IONS since 2021. Their most recent trade was a sale of 8,341 shares, made on Oct 30, 2025. Their largest trade was a sale of 16,800 shares, made on Oct 01, 2025. We estimate that they now own 64,035 shares of $IONS, worth an estimated $6.8 million.
Insider Trading at $IONS
There have been a total of 215 insider trades reported at $IONS since 2021, with 20,000 shares purchased and 2.0 million shares sold. The most active insider traders in $IONS stock have been Brett P Monia, Patrick R. O'Neil, and Richard S Geary. The most recent trade was a sale of 8,000 shares reported by Brian Birchler (EVP, Corp and Development Ops), made on Nov 06, 2025.
History of Insider Stock Trades by Joseph H Wender
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IONS
|
Sale | 8,341 | Oct 30, 2025 | Nov. 3, 2025, 9:14 p.m. |
|
IONS
|
Sale | 2,484 | Oct 30, 2025 | Nov. 3, 2025, 9:14 p.m. |
|
IONS
|
Sale | 11,200 | Oct 31, 2025 | Nov. 3, 2025, 9:14 p.m. |
|
IONS
|
Sale | 5,975 | Oct 30, 2025 | Nov. 3, 2025, 9:14 p.m. |
|
IONS
|
Sale | 16,800 | Oct 01, 2025 | Oct. 2, 2025, 7:36 p.m. |
|
IONS
|
Sale | 11,200 | Sep 02, 2025 | Sept. 4, 2025, 8:40 p.m. |
|
IONS
|
Sale | 5,600 | Sep 02, 2025 | Sept. 4, 2025, 8:40 p.m. |
|
IONS
|
Sale | 11,200 | Sep 03, 2025 | Sept. 4, 2025, 8:40 p.m. |
|
IONS
|
Sale | 11,200 | Sep 03, 2025 | Sept. 4, 2025, 8:34 p.m. |
|
IONS
|
Sale | 5,600 | Sep 02, 2025 | Sept. 4, 2025, 8:34 p.m. |
|
IONS
|
Sale | 11,200 | Sep 02, 2025 | Sept. 4, 2025, 8:34 p.m. |
$IONS Executives and Stock Owners with Insider Trades
-
Brett P Monia, Chief Executive Officer
-
Patrick R. O'Neil, EVP CLO & General Counsel
-
Richard S Geary, EVP, Chief Development Officer
-
Eric Swayze, EVP Research
-
C Frank Bennett, EVP, Chief Scientific Officer
-
Joseph Baroldi, EVP, Chief Business Officer
-
Eugene Schneider, EVP, Chf Clinical Develop Ofcr
-
Brian Birchler, EVP, Corp and Development Ops
-
Elizabeth L Hougen, EVP, Finance & CFO
-
Onaiza Cadoret-Manier, EVP, Chf GL Pdt Str & Oper Ofc
-
Shannon L. Devers, EVP, Chief Human Resources Ofc
-
Kyle Jenne, EVP, Chf GL Pdt Str Ofcr
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.